Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on March 4, 2025
ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger
GlobeNewswire
·
March 4, 2025
Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN) and Alumis Inc. (Nasdaq: ALMS) today …
VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management
GlobeNewswire
·
March 4, 2025
VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- VIVUS, LLC., a biopharmaceutical company committed to the development and commercialization of …
ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger
GlobeNewswire
·
March 4, 2025
All-Stock Transaction with Alumis Maximizes Long-Term Value for ACELYRIN Stockholders LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and …
MIND CTI Reports Fourth Quarter and Full Year 2024 Results
GlobeNewswire
·
March 4, 2025
* Board Declares Cash Dividend * MIND CTI to Host Annual Meeting of Shareholders YOQNEAM, Israel, March 04, 2025 (GLOBE NEWSWIRE) -- MIND C.T.I. LTD. – (NasdaqGM: MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care …
Palisade Bio Participates in Virtual Investor “What This Means” Segment
GlobeNewswire
·
March 4, 2025
Dr. Joerg Heyer, Head of Translational Science and Medicine of Palisade Bio highlights preclinical data for lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC) Carlsbad, CA, March 04, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. …
Alarum to Release Fourth Quarter and Full Year 2024 Results on March 20, 2025
GlobeNewswire
·
March 4, 2025
Conference call scheduled for Thursday, March 20, 2025, at 8:30 a.m. ET Tel Aviv, Israel, March 04, 2025 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq, TASE: ALAR), a global provider of web data collection solutions, will release its financial …
Discure Technologies Accepted into FDA TAP Program for Its Breakthrough Device for Degenerative Disc Disease
GlobeNewswire
·
March 4, 2025
PETACH-TIKVA, Israel, March 04, 2025 (GLOBE NEWSWIRE) -- Discure Technologies, a clinical-stage medical device company pioneering treatments for degenerative disc disease and other orthopedic disorders, today announced its acceptance into the U.S. Food and …
Neumora Therapeutics to Present at Leerink Global Healthcare Conference
GlobeNewswire
·
March 4, 2025
WATERTOWN, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced …
Celldex Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
March 4, 2025
HAMPTON, N.J., March 04, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences: TD Cowen 45th Annual Health Care Conference on Tuesday, March 4th at …
BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
GlobeNewswire
·
March 4, 2025
BURLINGTON, Mass. and JERUSALEM, March 04, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …
Aryon Security Raises $9M in Seed Funding to Transform Cloud Security Industry
GlobeNewswire
·
March 4, 2025
Radical prevention-first model attracts preeminent VC firms and serial cybersecurity entrepreneurs Leverages insights founders gained from Israel’s most sensitive national cloud infrastructure project Nimbus TEL AVIV, Israel, March 04, 2025 (GLOBE NEWSWIRE …
Praxis Precision Medicines to Participate in Five Upcoming Investor Conferences
GlobeNewswire
·
March 4, 2025
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
March 4, 2025
MONTREAL and CHARLOTTE, N.C., March 04, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 94,000 options (the “Options”) …
Infinidat is Recognized as a 2025 Gartner® Peer Insights™ Customers’ Choice for Primary Storage Platform for the Seventh Time: 5 Times as an Overall Customers’ Choice and 2 Times as a North America Region Customers’ Choice
GlobeNewswire
·
March 4, 2025
WALTHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that the company has been named a 2025 Gartner® Peer Insights™ Customers’ Choice in the Gartner Peer Insights “Voice of the …
Hexiris Welcomes Paul Sowyrda and Steven Schiffman to Its Board of Directors
GlobeNewswire
·
March 4, 2025
DIEPPE, New Brunswick, March 04, 2025 (GLOBE NEWSWIRE) -- Hexiris Inc. (“Hexiris” or the “Company”), a leading R…
American Tungsten Corp. Joins U.S. Defense Industrial Base Consortium
GlobeNewswire
·
March 4, 2025
Vancouver, BC, March 04, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that the Company’s application to the U.S. Defense Industrial Base Consortium (the “ …
Highland Copper Receives Approval for Updated Air Permit Application
GlobeNewswire
·
March 4, 2025
VANCOUVER, British Columbia, March 04, 2025 (GLOBE NEWSWIRE) -- Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) (“Highland Copper” or the “Company”) is pleased to announce the approval of its updated air permit application (known as Permit to Install …
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications
GlobeNewswire
·
March 4, 2025
Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and Angiofibromas Proprietary Invisicare Delivery Technology Designed to Optimize Local Skin Penetration Company Plans to Submit Investigational New Drug Applications and …
Nayax Reports Fourth Quarter and Full Year 2024 Results
GlobeNewswire
·
March 4, 2025
Full Year revenue of $314.0 million, recurring revenue growth of 47% YoY On a constant currency basis revenue of $315.2 million, a 34% increase Adjusted EBITDA of $35.5 million (1) and Free Cash Flow of $18 million (1) for the year 2025 Revenue guidance of …
Beamr Issues Annual CEO Letter to Shareholders: Highlighting 2024 Achievements and 2025 Strategy - Capitalizing on Market Validation
GlobeNewswire
·
March 4, 2025
In 2025, Beamr plans to leverage the strong market validation it has gained in numerous meetings with prospective customers across key target markets, as well as participation in major events with industry leaders Herzliya, Israel, March 04, 2025 (GLOBE …